Researchers conducted a single-center study involving 65 healthy subjects aged 65 and older. They looked for the presence of a posterior precortical vitreous pocket, a structure in the eye's vitreous gel. The main goal was to see if this structure changed the thickness and volume of the macula, the part of the retina responsible for sharp vision. The team also measured vessel density in the eye. They compared people with this pocket to those without it. The study found that the retinal thickness in the superior inner macula was significantly greater in the group with the pocket compared to the group without it. Specifically, the thickness was 362.91 micrometers versus 344.06 micrometers. About 72 percent of the participants had this structure. No safety concerns were reported during the study, and there were no adverse events. Because this was a small, single-center study, the results may not apply to everyone. The findings suggest a link between the eye structure and retinal thickness, but more research is needed to understand the full picture.
Posterior precortical vitreous pocket associated with greater retinal thickness in 47 of 65 healthy subjectsA glass pocket in the eye is linked to thicker retinal tissue in healthy older adults
AI-generated summary of the cited source, checked by automated accuracy review. How we work
A prospective single-center study assessed macular retinal thickness, volume, and vessel density in 65 healthy subjects. The population was divided into a PPVP-positive group and a PPVP-negative group. Among the 65 subjects, 47 had PPVP.
The primary outcome measured retinal thickness in the superior inner macula. Results showed that thickness was significantly greater in the PPVP-positive group compared with the PPVP-negative group. The mean thickness was 362.91 ± 16.84 µm for the PPVP-positive group versus 344.06 ± 15.59 µm for the PPVP-negative group. The difference was statistically significant with a p-value less than 0.05.
Safety and tolerability data were not reported, as no adverse events, serious adverse events, discontinuations, or specific tolerability metrics were captured in the study. The study design was prospective and single-center, which may limit generalizability. Because the participants were healthy subjects, the clinical relevance for patients with retinal disease remains uncertain. The study does not establish a causal link between PPVP and retinal thickening.